Literature DB >> 28721905

Inter- and Intrafractional Variation in the 3-Dimensional Positions of Pancreatic Tumors Due to Respiration Under Real-Time Monitoring.

Mami Akimoto1, Mitsuhiro Nakamura2, Akira Nakamura1, Nobutaka Mukumoto1, Takashi Kishi1, Yoko Goto1, Takashi Mizowaki1, Masahiro Hiraoka1.   

Abstract

PURPOSE: To quantify the 3-dimensional pancreatic tumor motion during the overall treatment course using real-time orthogonal kilovoltage X-ray imaging. METHODS AND MATERIALS: This study included 10 patients with pancreatic cancer who underwent 6-port static intensity modulated radiation therapy with real-time tumor tracking in 15 fractions, except for 1 patient (5 fractions). The tumor and abdominal wall positions were acquired simultaneously during the overall treatment course. Then the tumor motion amplitude and reference positions were determined.
RESULTS: The mean tumor amplitudes were 4.9, 6.5, and 13.4 mm in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions, respectively. The intrafractional variations of the reference tumor position were up to 5.4, 10.2, and 10.7 mm in the LR, AP, and SI directions, and those of the reference abdominal position were up to 10.5 mm. The reference tumor position drifted significantly in the AP and SI directions after 10 minutes, and that of abdominal wall motion drifted during the first 15 minutes (P<.05). The interfractional variation of the reference tumor position after setup correction, based on bony structures, was up to 8.9, 9.8, and 11.0 mm in the LR, AP, and SI directions, respectively.
CONCLUSIONS: Appropriate respiratory motion management techniques should be applied for the accurate localization of pancreatic tumors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28721905     DOI: 10.1016/j.ijrobp.2017.03.042

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  A Pilot Study of Synchronization of Respiration-Induced Motions in the Duodenum and Stomach for the Primary Tumor in Radiation Therapy for Pancreatic Cancer Using 4-Dimensional Computed Tomography.

Authors:  Rei Umezawa; Akihisa Wakita; Yoshiyuki Katsuta; Yoshinori Ito; Satoshi Nakamura; Hiroyuki Okamoto; Noriyuki Kadoya; Kana Takahashi; Koji Inaba; Naoya Murakami; Hiroshi Igaki; Keiichi Jingu; Jun Itami
Journal:  Adv Radiat Oncol       Date:  2021-05-27

Review 2.  Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?

Authors:  Constantin Dreher; Daniel Habermehl; Oliver Jäkel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2017-12-27       Impact factor: 3.481

3.  Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac.

Authors:  Yoko Goto; Ryo Ashida; Akira Nakamura; Satoshi Itasaka; Keiko Shibuya; Mami Akimoto; Nobutaka Mukumoto; Shigemi Matsumoto; Masashi Kanai; Hiroyoshi Isoda; Toshihiko Masui; Yuzo Kodama; Mitsuhiro Nakamura; Kyoichi Takaori; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Oncotarget       Date:  2018-05-04

4.  Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning study.

Authors:  Ryo Ashida; Mitsuhiro Nakamura; Michio Yoshimura; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2020-04-30       Impact factor: 2.102

5.  Positional repeatability and variation in internal and external markers during volumetric-modulated arc therapy under end-exhalation breath-hold conditions for pancreatic cancer patients.

Authors:  Makoto Sasaki; Mitsuhiro Nakamura; Tomohiro Ono; Ryo Ashida; Michio Yoshimura; Manabu Nakata; Takashi Mizowaki; Naozo Sugimoto
Journal:  J Radiat Res       Date:  2020-09-08       Impact factor: 2.724

6.  Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.

Authors:  Makoto Sasaki; Mitsuhiro Nakamura; Nobutaka Mukumoto; Yoko Goto; Yoshitomo Ishihara; Manabu Nakata; Naozo Sugimoto; Takashi Mizowaki
Journal:  J Appl Clin Med Phys       Date:  2019-09-20       Impact factor: 2.102

7.  Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?

Authors:  Colin S Hill; Sarah Han-Oh; Zhi Cheng; Ken Kang-Hsin Wang; Jeffrey J Meyer; Joseph M Herman; Amol K Narang
Journal:  Radiat Oncol       Date:  2021-03-19       Impact factor: 3.481

8.  Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.

Authors:  Sebastian Zschaeck; Bibiana Blümke; Peter Wust; David Kaul; Marcus Bahra; Hanno Riess; Fritz Klein; Marianne Sinn; Uwe Pelzer; Volker Budach; Pirus Ghadjar
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

9.  Reliability of ITV approach to varying treatment fraction time: a retrospective analysis based on 2D cine MR images.

Authors:  Davide Cusumano; Jennifer Dhont; Luca Boldrini; Giuditta Chiloiro; Angela Romano; Claudio Votta; Silvia Longo; Lorenzo Placidi; Luigi Azario; Marco De Spirito; Dirk Verellen; Vincenzo Valentini
Journal:  Radiat Oncol       Date:  2020-06-12       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.